Clinical Trial Update: Metformin in Patients With Unruptured Vertebrobasilar Dissecting Aneurysms (METTLE) [NA]

View source ↗

Summary

METTLE is a clinical trial evaluating metformin for unruptured vertebrobasilar dissecting aneurysms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dissecting Aneurysm of Cerebral Artery

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Ming Lv | Conditions: Dissecting Aneurysm of Cerebral Artery | NA | Status: RECRUITING